M2Test is a start-up that operates as a Software as a Service (SAAS) providing analysis services for the evaluation of the elasticity and fragility of the bone. M2Test aims to improve people’s lives through the assessment of the risk of fragile fracture, and to this aim, they have developed BES TEST (Bone Elastic Structure TEST), a test for assessing the elasticity (quality) of the bone internal structure.
Founded in Trieste on 6 October 2016 by Francesca Cosmi and Alessandra Nicolosi, M2Test pays particular attention to specialization and innovation. They aim to improve life by providing a unique solution that is easy to implement, not invasive, and can monitor the real risk of bone fracture, helping the physician in keeping the disease under control and satisfying the growing demand for greater efficiency, constant quality, and safety in the diagnosis of fracture risk.
BES TEST: The Revolutionary Test for Bone Fracture Risk Assessment
BES TEST is based on the simulation of the application of forces on a virtual biopsy of the patient’s bone architecture, obtained from low-dose radiographic images. It was developed over a period of 15 years as part of the research activities carried out at the University of Trieste by Francesca Cosmi, a professor of Mechanical Engineering. Starting from the engineering models used to simulate the behavior of structures, Francesca over the years developed and defined an analysis process that allows determining the structural quality of the bone through simulations of the elastic behavior of its internal structure, detected by a plane radiographic image.
The method used by BES TEST is covered by an American patent whose sole author is Francesca Cosmi (co-founder and majority shareholder) and an Italian patent. Additional innovative aspects related to M2TEST’s core business have recently been deposited in the USA and extended by PCT. BES TEST is considered a software medical device, registered by the Italian Ministry of Health, and has already obtained the CE mark and the ISO 13485 qualification.
Collaboration with Early Adopters and Hospitals
To date, M2Test collaborates with 16 early adopters and several hospitals in Italy, both private medical practices and multi-specialized centers. Thousands of patients have benefited from the BES TEST exam. The test is useful for diagnosing, monitoring, and preventing the bone alterations that cause fragility.
M2Test’s Impact on the Healthcare Industry
M2Test’s innovative solution for assessing the elasticity and fragility of bones has the potential to revolutionize the healthcare industry. By providing an easy-to-implement, non-invasive solution that can monitor the real risk of bone fracture, M2Test is helping physicians keep diseases under control and meet the growing demand for greater efficiency, constant quality, and safety in the diagnosis of fracture risk.
M2Test is a promising start-up that is improving people’s lives through its innovative solution for assessing the elasticity and fragility of bones. With BES TEST, M2Test has developed a unique solution that is easy to implement, non-invasive, and can monitor the real risk of bone fracture. By collaborating with early adopters and hospitals in Italy, M2Test has already made a significant impact on the healthcare industry.
Website: http://www.bestest.it/
LinkedIn: https://www.linkedin.com/company/m2test
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!
